Novel strategies of preventions and therapies for esophageal cancer using bioactive molecules derived from oral flora or probiotics

Novel strategies of preventions and therapies for esophageal cancer using bioactive molecules derived from oral flora or probiotics - Novel strategies of preventions and therapies for esophageal cancer using bioactive molecules derived from oral flora or probiotics

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025105

Enrollment

Registered

2016-12-05

Start date

2016-12-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal squamous cell carcinoma, esophageal adenocarcinoma, esophageal squamous dysplasia, Barrett&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with esophageal cancer and precancerous lesions who undergo esophagogastroduodenoscopy are enrolled the study. As a control group, patients without esophageal abnormalities who undergo esophagogastroduodenoscopy are enrolled the study.

Exclusion criteria

Exclusion criteria: 1. In case patients would like to exclude the study. 2. In case the doctors in charge of the study judge patients should be excluded the study due to general condition or treatment progress. 3. In case the study is canceled. 4. In case the doctors in charge of the study judge patients should be excluded due to any other reasons.

Design outcomes

Primary

Measure	Time frame
To detect the oral bacteria related to the pathogenesis of esophageal cancer/precancerous lesion	—

Countries

Japan

Contacts

Public ContactKentaro Moriichi

Asahikawa Medical University Division of Gastroenterology, Department of Internal Medicine

morimori@asahikawa-med.ac.jp0166-68-2462

Outcome results